The SLEEP meeting is the world’s premier forum on sleep medicine, and sleep and circadian research with attendees from around the world.
In Keynote Address, Dr Susan Redline Refutes Report Claiming CPAP May Not Improve Health Outcomes
June 7th 2022Susan Redline, MD, MPH, the SLEEP 2022 meeting keynote speaker, catalogued the evidence proving that continuous positive airway pressure (CPAP) does improve health outcomes—refuting a recent controversial report that claims otherwise.
Read More
Dr John Winkelman Emphasizes Importance of Long-term Research on Opioids for Restless Leg Syndrome
June 6th 2022Opioids have been used for hundreds of years to treat restless leg syndrome (RLS), but there is currently a registry to understand the long-term effectiveness of opioids to treat RLS , said John Winkelman, MD, PhD, medical director, sleep disorders clinical research program, Massachusetts General Hospital.
Read More
Race Is Not a Risk Factor for Disrupted Sleep, but Racism Is
June 6th 2022A panel of experts at the SLEEP 2022 conference argued against considering race a risk factor for health complications and disrupted sleep, saying that being on the receiving end of racial discrimination is the true risk factor.
Read More
Abstracts Highlight Association Between Idiopathic Hypersomnia and Weight, Social Relationships
June 5th 2022Posters from the SLEEP 2022 conference revealed some of the interaction between idiopathic hypersomnia and different aspects of life, including weight changes and interpersonal relationships.
Read More
Dr Michael Thorpy Discusses the Efficacy of Solriamfetol on EDS Associated With Narcolepsy
June 15th 2021Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore Medical Center, and professor of neurology, Albert Einstein College of Medicine, speaks on the efficacy of solriamfetol observed in patients with excessive daytime sleepiness associated with narcolepsy, and which patient groups may best benefit from this therapy.
Read More
Dr Anne Marie Morse Addresses Screening for OSA in Patients With Stroke
June 13th 2021Anne Marie Morse, DO, pediatric neurologist and sleep medicine specialist, Geisinger, discusses factors contributing to insufficient screening of obstructive sleep apnea (OSA) in patients with stroke and how a team-based approach fared in expediting diagnosis.
Read More
Dr Isabelle Arnulf Highlights Efficacy, Safety of Lower-Sodium Oxybate in Idiopathic Hypersomnia
June 12th 2021Isabelle Arnulf, MD, PhD, senior neurologist, and professor, Neurology, Sorbonne Universités, Pierre and Marie Curie University, discusses findings of significant improvement observed in patients with idiopathic hypersomnia undergoing lower-sodium oxybate treatment.
Read More
Dr Katharine Simon on Contributors to Autonomic Dysfunction, Implications for Sleep and Health
June 12th 2021Katharine Simon, PhD, clinical pediatric psychologist, and postdoctoral researcher, Sleep and Cognition Lab, UC Irvine, explains the influence of the autonomic nervous system on body functions and recommendations for patients experiencing autonomic imbalance and sleep dysregulation.
Read More
Dr Michael Thorpy on Mechanisms, Applicability of the Idiopathic Hypersomnia Severity Scale
June 11th 2021Michael Thorpy, MD, director of the Sleep-Wake Disorders Center, Montefiore, and professor of neurology, Albert Einstein College of Medicine, discusses aspects of the Idiopathic Hypersomnia Severity Scale, and how it fared in measuring symptoms of idiopathic hypersomnia compared with traditional scales.
Read More
Dr Rebecca Spencer on Potential Takeaways, Topics of Interest at SLEEP 2021
June 9th 2021Rebecca Spencer, PhD, professor, Department of Psychological and Brain Sciences, University of Massachusetts Amherst, and co-chair of SLEEP 2021, highlights takeaways from this year’s meeting and discussions she’s looking forward to.
Read More
Dr Shalini Paruthi Speaks on Upcoming Sessions, Discussions at SLEEP 2021
June 7th 2021Shalini Paruthi, MD, medical codirector, St. Luke’s Hospital Sleep Medicine and Research Center, and cochair of SLEEP 2021, discusses the sessions and discussions she is looking forward to at this year's meeting.
Read More
Restless Legs Syndrome/Willis-Ekbom Disease Diagnostic Criteria: Why Change?
June 6th 2013In this session, Daniel Picchietti, MD, discussed changes to the diagnostic guidelines for restless legs syndrome/Willis-Ekbom disease published jointly by the International Restless Legs Syndrome Study Group and the National Institutes of Health.
Read More
Managing Restless Leg Syndrome: Current Strategies and Treatment Guidelines
June 6th 2013In this session, Stephany Fulda, PhD, discussed the common causes of restless leg syndrome (RLS), considerations for the clinical application of treatment strategies for RLS, and changes to treatment guidelines for RLS that may be on the horizon.
Read More
Sleep and Sleep Disorders: Comorbid Conditions and Pathophysiology
June 4th 2013Dr Thomas Roth, PhD, presented on the evolution of our understanding of insomnia, and the importance of insomnia in the context of other disease states. Roth noted that insomnia is primarily a disorder of increased wakefulness from a pathophysiologic standpoint, and presented data to support this. Presenting the effect of improved sleep on diseases such as depression, worker productivity, and cardiovascular disease, Roth revealed rich prospects for the future of sleep medicine in treating a variety of disorders.
Read More
Dr Sharon Discusses How Insurers Have Responded to the Availability of Therapies for RLS
June 4th 2013In this video, Denise Sharon, MD, PhD, Clinical Director and Founding Partner, Comprehensive Sleep Medicine Center of the Gulf Coast, discusses how insurers have responded to the availability of therapies and changes in clinical practice guidelines for RLS.
Read More